Shoppers urged to change expectations as food disease found in Australia for first time
Potato mop-top virus has only been detected in farms in Tasmania, a state that produces more than 30 per cent of the nation's crop, but how far it has spread and when it first arrived in the country is still under investigation.
Luckily, infected potatoes are perfectly safe to eat, but unfortunately the disease causes ugly discolouration of their flesh and bumps on the skin, and it is incredibly difficult to get rid of.
Dr Nigel Crump, a potato pathologist with over 20 years' experience in the industry, explained the slime mould vector that transmits the virus can survive in the soil for up to 20 years. 'The good news is spongospora subterranea doesn't spread in the wind, but it lives in the soil and only really affects potatoes,' he told Yahoo News.
Crump doesn't expect most shoppers will encounter infected potatoes because supermarkets generally reject food with defects. 'Australia has a high preference for having perfect potatoes, but at the end of the day much of it is cut or peeled off. So we need to educate consumers,' he said.
As the director of peak body Potatoes Australia, he's mostly concerned that the virus could result in more food waste. 'That's going to be a real concern, because it could affect farmers' profits,' he said.
Potato mop-top virus can affect the leaves, shoots and tubers of potato plants, and studies in Scotland have shown that in a worst-case scenario, it can cause yield reductions of 67 per cent.
The virus is widespread around much of the world, and is established across the US, Canada, Europe, South America and parts of Asia. In New Zealand, it's been well managed since it was first detected in 2018.
Australia has been well prepared for its arrival here, and in 2022, the nation's seed certification inspectors were trained by a United States expert. The virus was first detected in July, but throughout the year, all exported potato seeds have been screened with PCR tests, similar to those used to detect Covid-19 to ensure they weren't infected.
Will the cost of potatoes increase?
Australian National University supply chain expert David Leaney explained that acting swiftly to contain the spread will be essential to containing its impact on Australian consumers. Because the wholesale and retail prices for potatoes could increase if the virus becomes widespread.
If that were to occur, processors would face increased costs in sourcing acceptable potatoes, and farmers in Tasmania could find their shipments subject to quarantine, stricter inspections, or even rejection.
Another cost farmers could face is the need to invest in enhanced biosecurity, seed certification, and soil management. He doesn't think shoppers would be looking at a large increase, but something closer to five or 10 per cent.
'It doesn't mean that only the price of Tasmanian potatoes is going to go up. Because of the state's significance to the Australian market, people buying potatoes in Sydney, could also see the price go up,' Leaney told Yahoo News.
Disease outbreaks have changed the way we farm
As Australia continues to embrace global trade, breaches of biosecurity are becoming a regular occurrence. Recent outbreaks include shot-hole borer in Perth that has resulted in the destruction of thousands of trees, fire ants which are spreading south from Queensland and threaten native species and agriculture, and varroa mite in NSW which attacks honey bees.
The nation is becoming more adept at responding to invasive diseases, and its experts are well aware of the harm outbreaks have caused in previous decades to food supply.
Leaney notes an outbreak in the 1950s of a strain of Panama disease, a soil-borne fungus that attacks the roots of banana plants, resulted in a global shift from Gros Michel bananas to Cavendish. And the citrus greening bacteria that causes bitter, misshapen fruit and irreversible orchard decline reduced orange production by up to 75 per cent between 2003 and 2023 in Florida, resulting in widespread job losses.
Bitter tasting food linked to surprising health benefits
Beach walker stumbles upon new Australian ocean predator with 'extremely sharp' teeth
Incredible predator discovery inside remote Aussie island cave with no public access
The fungal disease wheat stem rust has reduced yields by 70 to 100 per cent in some parts of Africa. While over in Brazil, severe outbreaks of soya bean rust have led to losses of up to 80 per cent without fungicide treatment, creating volatility in global prices, because the nation is a major producer.
Leaney explained that history shows the best way to control vector-borne diseases is containment and resistance breeding, because they are too difficult to eradicate. But developing new varieties of plants can take years, meaning affected farmers may need to abandon infected fields in the meantime.
Reports of the disease can be made to Biosecurity Tasmania, or the Exotic Plant Pest Hotline at 1800 084 881. The public will be updated online at www.nre.tas.gov.au/currentalerts
Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
an hour ago
- Fox News
Bindi Irwin's painful medical journey ends with life-changing surgeries
After 13 years of "fighting for answers," Bindi Irwin says she is finally healing. In a heartfelt Instagram post, the conservationist revealed the removal of 51 endometriosis lesions, a chocolate cyst, her appendix, and repair of a hernia from childbirth. Dr. Tamer Seckin, an endometriosis specialist, removed them all during two separate surgeries. "I felt utterly ashamed as a teenager and young adult," Irwin wrote, speaking about the painful endometriosis symptoms she suffered. Her message? No young woman should feel ashamed or alone with pain that's too often dismissed as "just part of being a woman." Irwin, daughter of the late "Crocodile Hunter" Steve Irwin, first revealed her diagnosis in March 2023, through a post on social media. The conservationist's story highlights a condition affecting millions worldwide. Here's what to know. What is endometriosis? Endometriosis affects roughly 10 percent of reproductive-aged women worldwide; in the U.S. alone, it impacts about 9 million women. Diagnosis is often delayed, averaging five to 12 years after onset of symptoms due to stigma and misdiagnosis, according to research published in the Journal of the American Medical Association. The World Health Organization defines endometriosis as a condition that occurs when tissue like the uterine lining grows outside the uterus, causing pain, inflammation, and even infertility. Common symptoms include pelvic and abdominal pain, painful periods, pain during intercourse, digestive issues, heavy bleeding, and fatigue. When treatment doesn't help symptoms, the next step is often laparoscopic surgery, which uses small incisions to remove or ablate lesions. This surgery often means a faster recovery and fewer complications compared to more invasive open surgery, called a laparotomy, which involves one long incision across the abdomen. Recovery typically takes two to four weeks, though healing may take longer depending on the extent of surgery and individual health. While relatively rare, risks of the surgery can include infection, bleeding, damage to nearby organs, and gas-related discomfort. Beyond symptom relief, procedures like Irwin's may preserve fertility by removing growths. In May 2025, the Seckin Endometriosis Research Center opened at Cold Spring Harbor Laboratory, backed by $20 million in funding. It represents the first major U.S. facility solely dedicated to understanding endometriosis, developing non-invasive diagnostics, and improving treatments. For more Health articles, visit Irwin's story sheds light on the difficult battle many women face when trying to find answers to their physical pain. Her post urges broader, open conversations about women's health on a global scale. "I can function in everyday life without wanting to throw up or pass out from the pain," Irwin shared. "Slowly, slowly gaining my strength back. I cannot express the gravity of my emotions as I am beginning to recognize myself again."
Yahoo
12 hours ago
- Yahoo
Radiopharm Theranostics Limited (RADX) Receives IND Approval From FDA To Initiate Phase I Therapeutic Clinical Study To Target B7H3 With Betabart (RV-01)
Radiopharm Theranostics Limited (NASDAQ:RADX) is among the 12 Best Australian Stocks to Buy Right Now. The company recently announced receiving Investigational New Drug (IND) approval from the FDA to begin a Phase 1 therapeutic clinical study to target B7H3 with Betabart (RV-01). A well-stocked pharmacy shelf full of the company's pharmaceuticals, nutraceuticals, over-the-counter medications, and health care products. The Lu-177-B7H3 monoclonal antibody is the first in class targeted radiopharmaceutical that is being developed against the 4lg type of B7H3. Radiopharm Theranostics Limited (NASDAQ:RADX) believes it has the potential to become a highly differentiated drug for treating individuals with aggressive solid tumors. The company says it is on track to initiate the first-in-human study during the fourth quarter of this calendar year. Findings from recent preclinical studies have shown that RV-01 exhibits hepatic clearance, which allows the isotope enough time to target tumors, while also potentially reducing adverse effects such as hematological toxicities. Moreover, these monoclonal antibodies are cleared by the liver, unlike peptides and small molecules. This, coupled with the shortened half-life of RV-01, makes this agent stand out compared to other monoclonal antibodies and targeted radiotherapeutics with a renal excretion pathway. Radiopharm Theranostics Limited (NASDAQ:RADX) is an Australia-based clinical-stage radiotherapeutics firm developing innovative radiopharmaceutical products for therapeutic and diagnostic applications in areas of high unmet medical need. While we acknowledge the potential of RADX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 hours ago
- Yahoo
Incannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea
Incannex Healthcare Inc. (NASDAQ:IXHL) is among the 12 Best Australian Stocks to Buy Right Now. On August 8, the company announced positive new patient-reported outcomes from participants in its RePOSA Phase 2 trial of IHL-42X to treat obstructive sleep apnoea (OSA). A scientist in a lab coat examining a Petri dish containing a biopharmaceutical culture. The new insights were collected through exit interviews, in line with FDA's guidance on Patient-Focused Drug Development (PFDD). The results build on already compelling data to reinforce the potential of IHL-42X to improve sleep quality, cognitive function, and daily life. Incannex Healthcare Inc. (NASDAQ:IXHL) said that 57.6% of the respondents reported an improvement in their OSA, of which 89.5% described it as a meaningful change to their lives. Some of the reported benefits include better sleep quality, reduced sleepiness during the daytime, feeling fresh in the morning, and other cognitive and daily-life improvements. Joel Latham, President and CEO of Incannex Healthcare Inc. (NASDAQ:IXHL) stated the following on the findings: 'Our recent Phase 2 results for IHL-42X exceeded expectations. In some patients, we observed reductions in AHI of up to 83%, which is an extraordinary outcome and a powerful signal of the drug's potential. We believe the findings from the patient exit interviews underscore that these improvements are not just clinical—they are translating into meaningful, positive changes in patients' daily lives. This reinforces our belief that IHL-42X has the potential to significantly shift the treatment paradigm for OSA.' Incannex Healthcare Inc. (NASDAQ:IXHL) is a clinical-stage pharmaceutical company developing medicines to treat chronic conditions, including obstructive sleep apnea, generalized anxiety disorder, and rheumatoid arthritis. While we acknowledge the potential of IXHL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Large Cap Defense Stocks to Buy According to Analysts and 10 Best Low Priced Defense Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data